YU34501A - Postupak reaktivne kristalizacije radi povećanja veličine čestica - Google Patents

Postupak reaktivne kristalizacije radi povećanja veličine čestica

Info

Publication number
YU34501A
YU34501A YU34501A YUP34501A YU34501A YU 34501 A YU34501 A YU 34501A YU 34501 A YU34501 A YU 34501A YU P34501 A YUP34501 A YU P34501A YU 34501 A YU34501 A YU 34501A
Authority
YU
Yugoslavia
Prior art keywords
particle size
crystallization method
improve particle
reactive crystallization
products
Prior art date
Application number
YU34501A
Other languages
English (en)
Inventor
David Jon Ende
Thomas Charles Crawford
Neil Philip Weston
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of YU34501A publication Critical patent/YU34501A/sh

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/02—Crystallisation from solutions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/005—Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
    • B01F25/20—Jet mixers, i.e. mixers using high-speed fluid streams
    • B01F25/23—Mixing by intersecting jets
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J14/00—Chemical processes in general for reacting liquids with liquids; Apparatus specially adapted therefor
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/18—Stationary reactors having moving elements inside
    • B01J19/1806—Stationary reactors having moving elements inside resulting in a turbulent flow of the reactants, such as in centrifugal-type reactors, or having a high Reynolds-number
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/26—Nozzle-type reactors, i.e. the distribution of the initial reactants within the reactor is effected by their introduction or injection through nozzles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B61/00—Other general methods
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41—Preparation of salts of carboxylic acids
    • C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/43—Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F27/00—Mixers with rotary stirring devices in fixed receptacles; Kneaders
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00—Other mixers; Mixing plants; Combinations of mixers
    • B01F33/30—Micromixers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00049—Controlling or regulating processes
    • B01J2219/00051—Controlling the temperature
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00049—Controlling or regulating processes
    • B01J2219/00051—Controlling the temperature
    • B01J2219/00074—Controlling the temperature by indirect heating or cooling employing heat exchange fluids
    • B01J2219/00087—Controlling the temperature by indirect heating or cooling employing heat exchange fluids with heat exchange elements outside the reactor
    • B01J2219/00101—Reflux columns
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00049—Controlling or regulating processes
    • B01J2219/00164—Controlling or regulating processes controlling the flow

Abstract

Ovaj pronalazak daje postupak za sprovodjenje simultane hemijske reakcije i regulisane kristalizacije proizvoda primenom mlazeve fluida koji se sudaraju sa ciljem dobijanja proizvoda željenih karakteristika u pogledu veličine čestica.[This invention results in a procedure for the conducting of simultaneous chemical reaction and regulated crystallization of products by the application of fluid jets that collide with the aim to obtain products of desired characteristics with regard to the particle size.
YU34501A 2000-05-26 2001-05-16 Postupak reaktivne kristalizacije radi povećanja veličine čestica YU34501A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20762900P 2000-05-26 2000-05-26

Publications (1)

Publication Number Publication Date
YU34501A true YU34501A (sh) 2003-10-31

Family

ID=22771343

Family Applications (1)

Application Number Title Priority Date Filing Date
YU34501A YU34501A (sh) 2000-05-26 2001-05-16 Postupak reaktivne kristalizacije radi povećanja veličine čestica

Country Status (38)

Country Link
US (1) US6558435B2 (sh)
EP (1) EP1157726A1 (sh)
JP (1) JP2002028475A (sh)
KR (1) KR100408949B1 (sh)
CN (1) CN1183989C (sh)
AP (1) AP1321A (sh)
AR (1) AR029099A1 (sh)
AU (1) AU775613B2 (sh)
BG (1) BG105518A (sh)
BR (1) BR0102129A (sh)
CA (1) CA2349136A1 (sh)
CZ (1) CZ20011726A3 (sh)
DZ (1) DZ3075A1 (sh)
EA (1) EA003261B1 (sh)
EC (1) ECSP014083A (sh)
EE (1) EE200100284A (sh)
GE (1) GEP20043173B (sh)
GT (1) GT200100095A (sh)
HK (1) HK1038896B (sh)
HR (1) HRP20010399A2 (sh)
ID (1) ID30368A (sh)
IL (1) IL143227A (sh)
IS (1) IS5950A (sh)
MA (1) MA25321A1 (sh)
NO (1) NO20012571L (sh)
NZ (1) NZ511966A (sh)
OA (1) OA11719A (sh)
PA (1) PA8517001A1 (sh)
PE (1) PE20020149A1 (sh)
PL (1) PL347736A1 (sh)
SG (1) SG96223A1 (sh)
SK (1) SK6882001A3 (sh)
SV (1) SV2001000464A (sh)
TN (1) TNSN01075A1 (sh)
TR (1) TR200101453A2 (sh)
TW (1) TWI236930B (sh)
YU (1) YU34501A (sh)
ZA (1) ZA200104207B (sh)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL157933A0 (en) * 2001-05-14 2004-03-28 Pfizer Prod Inc Tartrate salts of 5,8,14-triazatetracyclo [10.3.1.02,11.04,9] -hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
RU2004116311A (ru) * 2001-11-29 2005-03-27 Пфайзер Продактс Инк. (Us) Сукцинатные соли 5,8,14-триазатетрацикло [10.3.1.02,11(04,9]гексадека- 2(11),3,5,7,9-пентаена и их фармацевтические композиции
JP2005523811A (ja) * 2002-04-29 2005-08-11 ブリストル−マイヤーズ　スクイブ　カンパニー 噴霧化利用の結晶システム
US20040005257A1 (en) * 2002-05-10 2004-01-08 Chenkou Wei Crystallization system using homogenization
US20040098839A1 (en) * 2002-11-27 2004-05-27 Pfizer Inc. Crystallization method and apparatus using an impinging plate assembly
AU2003300814A1 (en) 2002-12-04 2004-06-23 Dr. Reddy's Laboratories Inc. Polymorphic forms of ziprasidone and its hydrochloride
WO2004050655A1 (en) * 2002-12-04 2004-06-17 Dr. Reddy's Laboratories Limited Polymorphic forms of ziprasidone and its hydrochloride
KR20080093164A (ko) * 2003-06-03 2008-10-20 테바 파마슈티컬 인더스트리즈 리미티드 결정성 지프라시돈 염산염 및 그의 제조 방법
TWI371274B (en) 2003-10-23 2012-09-01 Bristol Myers Squibb Co Process for making sterile aripiprazole of desired mean particle size
US7667037B2 (en) 2003-10-24 2010-02-23 Teva Pharmaceutical Industries Ltd. Processes for preparation of ziprasidone
WO2005065660A2 (en) * 2003-12-31 2005-07-21 Alpharma, Inc. Ziprasidone formulations
US20050256314A1 (en) * 2004-05-04 2005-11-17 Soojin Kim Process employing controlled crystallization in forming crystals of a pharmaceutical
US7829720B2 (en) 2004-05-04 2010-11-09 Bristol-Myers Squibb Company Process for preparing atazanavir bisulfate and novel forms
US7396932B2 (en) * 2004-09-28 2008-07-08 Bristol-Myers Squibb Company Process for preparing 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
US7314516B2 (en) * 2004-12-29 2008-01-01 Five Star Technologies, Inc. Hydrodynamic cavitation crystallization device and process
US20060160841A1 (en) * 2005-01-19 2006-07-20 Chenkou Wei Crystallization via high-shear transformation
DE102005053862A1 (de) 2005-11-04 2007-05-10 Pharmasol Gmbh Verfahren und Vorrichtung zur Herstellung hochfeiner Partikel sowie zur Beschichtung solcher Partikel
CA2640922A1 (en) * 2006-02-01 2007-11-22 Medichem, S.A. Process for preparing voriconazole, new polymorphic form of intermediate thereof, and uses thereof
CN101495095B (zh) * 2006-04-28 2013-05-29 默沙东公司 通过受控的沉淀来沉淀和分离6,6-二甲基-3-氮杂-双环[3.1.0]己烷-酰胺化合物的方法和含有其的药学制剂
EP2012753A2 (en) * 2006-04-28 2009-01-14 Schering Corporation Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0]hexane-amide compounds by controlled precipitation and pharmaceutical formulations containing same
US8420122B2 (en) * 2006-04-28 2013-04-16 Merck Sharp & Dohme Corp. Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0] hexane-amide compounds by controlled precipitation and pharmaceutical formulations containing same
KR100850010B1 (ko) * 2007-03-19 2008-08-04 희성금속 주식회사 초음파 화학적 반응에 의한 산화 인듐 분말의 제조방법 및ｉｔｏ 타겟재의 제조방법
KR100850011B1 (ko) * 2007-03-19 2008-08-04 희성금속 주식회사 초음파 화학적 반응에 의한 산화 주석 분말의 제조 방법 및ｉｔｏ 타겟재의 제조 방법
ATE499927T1 (de) * 2007-06-22 2011-03-15 Bristol Myers Squibb Co Tablettierte atazanavirhaltige zusammensetzungen
ES2449074T3 (es) * 2007-06-22 2014-03-18 Bristol-Myers Squibb Holdings Ireland Composiciones en forma de comprimidos que contienen atazanavir
JP2010530890A (ja) * 2007-06-22 2010-09-16 ブリストル−マイヤーズ スクイブ カンパニー アタザナビルを含む錠剤組成物
AU2008268537B2 (en) * 2007-06-22 2012-11-01 Bristol-Myers Squibb Holdings Ireland Tableted compositions containing atazanavir
EP2197446A4 (en) * 2007-08-31 2012-01-25 Reddys Lab Ltd Dr PREPARATION OF HYDROCHLORIDE OF ZIPRASIDONE MONOHYDRATE
WO2009101185A2 (en) * 2008-02-15 2009-08-20 Medichem, S.A. A NEW POLYMORPHIC FORM OF A PYRAZINO[2,3-h][3] BENZAZEPINE DERIVATIVE
EP2262780A4 (en) * 2008-03-06 2012-01-25 Reddys Lab Ltd Dr TARTRATE OF VARENICLINE AMORPHOUS
US8187554B2 (en) 2008-04-23 2012-05-29 Microfluidics International Corporation Apparatus and methods for nanoparticle generation and process intensification of transport and reaction systems
CA2709774C (en) 2008-05-22 2012-10-02 Teva Pharmaceutical Industries Ltd. Varenicline tosylate, an intermediate in the preparation process of varenicline l-tartrate
WO2009155403A2 (en) * 2008-06-19 2009-12-23 Teva Pharmaceutical Industries Ltd. Processes for the preparation of varenicline and intermediates thereof
US8219740B2 (en) * 2008-06-25 2012-07-10 International Business Machines Corporation Flash sector seeding to reduce program times
US20100010221A1 (en) * 2008-07-10 2010-01-14 Revital Lifshitz-Liron Processes for purifying varenicline l-tartrate salt and preparing crystalline forms of varenicline l-tartrate salt
DE102009008478A1 (de) 2009-02-11 2010-08-19 PHAST Gesellschaft für pharmazeutische Qualitätsstandards mbH Vorrichtung und Verfahren zur Herstellung pharmazeutisch hochfeiner Partikel sowie zur Beschichtung solcher Partikel in Mikroreaktoren
EP2438054A1 (en) 2009-06-22 2012-04-11 Teva Pharmaceutical Industries Ltd. Solid states forms of varenicline salts and processes for preparation thereof
US8288394B2 (en) 2009-12-30 2012-10-16 Medichem, S.A. 1-(1H-1,2,4-triazol-1-yl)butan-2-ol derivative for pharmaceutical use, and the use of a 1-(1H-1,2,4-triazol-1-yl)butan-2-ol derivative with substantially undefined crystal shape for preparing said 1-(1H-1,2,4-triazol-1-yl)butan-2-ol derivative
AU2011225747A1 (en) * 2010-03-09 2012-09-27 Actavis Group Ptc Ehf Highly pure varenicline or a pharmaceutically acceptable salt thereof substantially free of methylvarenicline impurity
KR101823706B1 (ko) 2010-03-22 2018-01-30 인스틸로 게엠베하 마이크로입자 또는 나노입자의 제조 방법 및 제조 장치
WO2011140431A1 (en) 2010-05-06 2011-11-10 Teva Pharmaceutical Industries Ltd. Varenicline salts and crystal forms thereof
KR101959934B1 (ko) 2010-09-28 2019-03-19 다우 글로벌 테크놀로지스 엘엘씨 직교류 장애물을 구비한 반응성 유동 정적 혼합기
US10350556B2 (en) 2011-01-07 2019-07-16 Microfluidics International Corporation Low holdup volume mixing chamber
US9199209B2 (en) 2011-04-13 2015-12-01 Microfluidics International Corporation Interaction chamber with flow inlet optimization
US9079140B2 (en) 2011-04-13 2015-07-14 Microfluidics International Corporation Compact interaction chamber with multiple cross micro impinging jets
US9732068B1 (en) 2013-03-15 2017-08-15 GenSyn Technologies, Inc. System for crystalizing chemical compounds and methodologies for utilizing the same
PL3119489T3 (pl) * 2014-03-19 2022-01-17 Basf Se Sposób oddzielania substancji z roztworu
CN104843745B (zh) * 2015-04-27 2016-08-24 青海国泰盐湖化肥有限公司 一种复分解法硝酸钾产品粒度的控制方法
CN106853295A (zh) * 2015-12-09 2017-06-16 北大方正集团有限公司 一种基于膜分散的结晶方法
CN108264457A (zh) * 2017-01-04 2018-07-10 辽宁药联制药有限公司 一种醋酸钾的制备方法
WO2019246615A1 (en) 2018-06-22 2019-12-26 Delphi Scientific, Llc Apparatus, systems, and methods for continuous manufacturing of nanomaterials and high purity chemicals
CN111346397B (zh) * 2020-03-11 2022-03-29 天津大学 适用于溶析结晶或反应结晶的加料设备
CN113980020B (zh) * 2021-11-22 2023-05-09 浙江车头制药股份有限公司 一种酒石酸伐尼克兰晶型的制备方法
CN114130324A (zh) * 2021-12-01 2022-03-04 沈阳铝镁设计研究院有限公司 一种蛟吸增效分解系统

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3330445A1 (de) * 1983-08-24 1985-03-21 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von als feststoffe anfallenden chemischen verbindungen aus fluessigen ausgangsstoffen
US4675194A (en) * 1986-03-03 1987-06-23 Reaction Technology, Inc. Sonic process for converting proteinaceous raw materials in situ into semi-solid food products
SE8700213L (sv) 1987-01-21 1988-07-22 Nobel Kemi Ab Sett att framstella kristallina substanser
CH671166A5 (en) 1987-07-01 1989-08-15 Fershan Holding S A Crystallisation nuclei formation - by turbulising soln. and applying mechanical energy to form nucleation sites
IE67187B1 (en) * 1990-06-15 1996-03-06 Merck & Co Inc A crystallization method to improve crystal structure and size
US5143965A (en) * 1990-12-26 1992-09-01 The Dow Chemical Company Magnesium hydroxide having fine, plate-like crystalline structure and process therefor
GB9313642D0 (en) 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
US5853691A (en) * 1993-08-10 1998-12-29 State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On The Behalf Of The University Of Oregon Silver halides of altered crystal habit or morphology and methods for producing same
GB9413202D0 (en) 1994-06-30 1994-08-24 Univ Bradford Method and apparatus for the formation of particles
DE4431872C1 (de) 1994-09-07 1996-01-11 Santrade Ltd Anwendung von Ultraschall bei der Verfestigung von Schmelzen oder übersättigten Lösungen auf Förderbändern oder Aufnahmetrommeln
SE9501384D0 (sv) 1995-04-13 1995-04-13 Astra Ab Process for the preparation of respirable particles
GB9624615D0 (en) 1996-11-26 1997-01-15 Zeneca Ltd Chrystallisation process
GB9703673D0 (en) 1997-02-21 1997-04-09 Bradford Particle Design Ltd Method and apparatus for the formation of particles

Also Published As

Publication number Publication date
ID30368A (id) 2001-11-29
JP2002028475A (ja) 2002-01-29
EA200100473A1 (ru) 2002-02-28
EP1157726A1 (en) 2001-11-28
HK1038896A1 (en) 2002-04-04
IS5950A (is) 2001-11-26
BG105518A (en) 2001-12-31
CN1326803A (zh) 2001-12-19
HK1038896B (zh) 2005-05-06
NZ511966A (en) 2002-11-26
AP1321A (en) 2004-10-27
BR0102129A (pt) 2002-05-21
IL143227A0 (en) 2002-04-21
TR200101453A3 (tr) 2001-12-21
EE200100284A (et) 2002-02-15
OA11719A (en) 2005-01-26
TWI236930B (en) 2005-08-01
KR100408949B1 (ko) 2003-12-06
ECSP014083A (es) 2003-01-13
TNSN01075A1 (fr) 2005-11-10
CA2349136A1 (en) 2001-11-26
AR029099A1 (es) 2003-06-04
GEP20043173B (en) 2004-02-25
SG96223A1 (en) 2003-05-23
MA25321A1 (fr) 2001-12-31
GT200100095A (es) 2003-12-12
KR20010107750A (ko) 2001-12-07
SK6882001A3 (en) 2002-04-04
PA8517001A1 (es) 2002-09-30
DZ3075A1 (fr) 2004-09-14
PE20020149A1 (es) 2002-02-26
TR200101453A2 (tr) 2001-12-21
AP2001002151A0 (en) 2001-06-30
AU4805601A (en) 2001-12-13
EA003261B1 (ru) 2003-02-27
PL347736A1 (en) 2001-12-03
SV2001000464A (es) 2001-07-03
CN1183989C (zh) 2005-01-12
CZ20011726A3 (cs) 2002-02-13
HRP20010399A2 (en) 2002-12-31
IL143227A (en) 2005-06-19
NO20012571D0 (no) 2001-05-25
AU775613B2 (en) 2004-08-05
US6558435B2 (en) 2003-05-06
ZA200104207B (en) 2002-11-25
NO20012571L (no) 2001-11-27
US20020016498A1 (en) 2002-02-07

Similar Documents

Publication Publication Date Title
YU34501A (sh) Postupak reaktivne kristalizacije radi povećanja veličine čestica
MY143994A (en) Aerated food products and methods for producing them
EP1413639A4 (en) HIGH RESISTANCE STEEL MATERIAL AND METHOD FOR PRODUCING STEEL PIPES USING THE SAME
CA2429412A1 (en) Production of fine-grained particles
AU2002211708A1 (en) Apparatus, methods and articles of manufacture for executing computerized transaction processes
AU2001257472A1 (en) Highly delaminated hexagonal boron nitride powders, process for making, and usesthereof
AU1613601A (en) Cleaning process which uses ultrasonic waves
AU2002355856A1 (en) An electroless process for treating metallic surfaces and products formed thereby
AU2001296991A1 (en) Apparatus, methods and articles of manufacture for constructing and executing computerized transaction processes and programs
MX2007010007A (es) Aparato y metodo para la produccion de hidrogeno.
AU2002238472A1 (en) Aqueous, effect-producing coating material, method for the production thereof and use of the same
EP1438421A4 (en) PRODUCTS CONTAINING FIXED QUANTITY OF BIOPARTICLES AND PROCESS FOR PRODUCING SAID PRODUCTS
MXPA03000357A (es) Metodos y mezclas de reaccion para controlar reacciones exotermicas.
IL142376A0 (en) Nanocomposites, process for making them and products made from them
AU2001256820A1 (en) Process and plant for the efficiency solubility of gas and sludge mixing
HUP0401095A3 (en) Electroporation reactor for continuously processing products in the form of pieces
PL364600A1 (en) Method for the production of hydrogen and applications thereof
MXPA02011882A (es) Metodo continuo para modificar el almidon y sus derivados por enzimas de ramificacion.
EP1596047A4 (en) PLASMA REACTION TANK AND PROCESS FOR PRODUCING THE SAME
SG128490A1 (en) Process for forming dispersant-coated carbon particles
AU2002219713A1 (en) Process and apparatus for the production of ammonia
AU2003228202A1 (en) Process for the production of nanoparticles, wherein low mechanical and sonic energies are used simultaneously
AU2002318562A1 (en) Liquid foods and process for producing the same
AU2002236908A1 (en) Systems, methods, and computer program products for determining the parameters for chemical synthesis and for supplying the reagents, equipment and/or chemicals synthesized thereby
AU2002344081A1 (en) Inorganic-particle-containing additive composition, process for producing the same, and food composition containing the additive composition